Jon advises pharmaceutical companies and specializes in integrating regulatory and patent exclusivity strategies in order to maximize the value of his clients’ products. He has worked on several Orange Book-listed products. He works closely with his clients to develop and implement patent strategies, with a particular focus on late-stage clinical trial inventions that provide significant additional patent protection. He also has experience conducting patentability, invalidity, freedom-to-operate/non-infringement analyses, IPOs, and due diligence for acquisitions and sales.
Download full bio